Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Neuropacs Corp.

News headline image
Neuropacs Announces the Publication of a New Study Comparing the First‑of‑Its‑Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease with CSF Alpha‑Synuclein Seed Amplification Assay
From Neuropacs Corp.
Via Business Wire
News headline image
FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes
From neuropacs Corp.
Via Business Wire
News headline image
Neuropacs Closes Seed Round of Financing
From neuropacs Corp.
Via Business Wire
News headline image
JAMA Neurology publishes landmark study showing neuropacs™ AI technology significantly enhances the diagnostic accuracy of Parkinson’s disease and atypical parkinsonism
From neuropacs Corp.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.